2,158 results on '"Liew, Danny"'
Search Results
2. An economic evaluation of the All New Zealand Acute Coronary Syndrome Quality Improvement Registry programme - subanalyses for Māori (ANZACS-QI 42)
3. Inappropriate prescribing and association with readmission or mortality in hospitalised older adults with frailty: a systematic review and meta-analysis
4. Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis
5. Sociocultural and Demographic Factors Predict Readmissions for General Surgery Patients
6. Prevalence and Predictors of Emergency Medical Service Use in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
7. Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022–2031
8. Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis
9. Delayed return of bowel function after general surgery in South Australia
10. A Causal Model for Primary Prevention of Cardiovascular Disease: The Health Economic Model for the Primary Prevention of Cardiovascular Disease
11. Adherence and Discontinuation of Disease-Specific Therapies for Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
12. Calling for Urgent Actions to Improve Lipid Management in Australia–Low Medication Adherence and Poor Therapeutic Goal Attainment Lead to Poor Outcomes and Wasted Resources
13. A Systematic Review of Cost-Effectiveness of Non-Statin Lipid-Lowering Drugs for Primary and Secondary Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
14. Prior Coronary Artery Bypass Graft Surgery Impacts 30-day Quality of Life after Percutaneous Coronary Intervention: Evidence from the Victorian Cardiac Outcomes Registry (VCOR): 30-day QoL after PCI in patients with prior CABG
15. Integrating the Biology of Cardiovascular Disease into the Epidemiology of Economic Decision Modelling via Mendelian Randomisation
16. Switching, Persistence and Adherence to Statin Therapy: a Retrospective Cohort Study Using the Australian National Pharmacy Data
17. Artificial intelligence for secondary prevention of myocardial infarction: A qualitative study of patient and health professional perspectives
18. Lost Therapeutic Benefit of Delayed Low-Density Lipoprotein Cholesterol Control in Statin-Treated Patients and Cost-Effectiveness Analysis of Lipid-Lowering Intensification
19. Effects of Statins for Secondary Prevention on Functioning and Other Outcomes Among Nursing Home Residents
20. Healthcare services use by patients with heart failure in Australia: Findings from the SHAPE study
21. The Hospitalizations for Cardiovascular and Respiratory Conditions, Emergency Department Presentations and Economic Burden of Bushfires in Australia Between 2021 and 2030: A Modelling Study
22. Cost-Effectiveness Analysis of Tobacco Control Strategies in Indonesia
23. Estimating the benefits of obesity prevention on productivity: an Australian perspective
24. Projected New-Onset Cardiovascular Disease by Socioeconomic Group in Australia
25. Real World Adherence to and Persistence With Oral Oncolytics in Multiple Myeloma: A Systematic Review and Meta-analysis
26. Long-Term Outcome of Multidisciplinary Versus Standard Gastroenterologist Care for Functional Gastrointestinal Disorders: A Randomized Trial
27. Attainment of Low-Density Lipoprotein Cholesterol Goals in Statin Treated Patients: Real-World Evidence From Australia
28. Trends in the Utilization of Lipid-Lowering Medications in Australia: An Analysis of National Pharmacy Claims Data
29. Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care
30. The association between polypharmacy, frailty and disability-free survival in community-dwelling healthy older individuals
31. Sex-Specific Outcomes Following Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Disease: A Systematic Review and Meta-Analysis
32. It doesn’t stop at validation: patient reported outcome measures require ongoing and iterative development
33. How does the onset of physical disability or dementia in older adults affect economic wellbeing and co-payments for health care? the impact of gender
34. A home-based, multidisciplinary liver optimisation programme for the first 28 days after an admission for acute-on-chronic liver failure (LivR well): a study protocol for a randomised controlled trial
35. Hospital revisits after paediatric tonsillectomy: a cohort study
36. Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system
37. The Health and Productivity Burden of Depression in South Korea
38. Productivity burden of hypertension in Japan
39. The effect of dihydroceramide desaturase 1 inhibition on endothelial impairment induced by indoxyl sulfate
40. SGLT2 Inhibitor–Associated Ketoacidosis vs Type 1 Diabetes–Associated Ketoacidosis
41. Infectious and sepsis presentations to, and hospital admissions from emergency departments in Victoria, Australia
42. Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition
43. Cost-effectiveness of Radial Access Percutaneous Coronary Intervention in Acute Coronary Syndrome
44. Cost Burden and Cost-Effective Analysis of the Nationwide Implementation of the Quality in Acute Stroke Care Protocol in Australia
45. Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility Analysis
46. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis
47. Clinical Outcomes in Older Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary Syndromes
48. Cost-effectiveness of treatment of women aged 70 years and older with both osteopenia and microstructural deterioration
49. Relation of Timing of Percutaneous Coronary Intervention on Outcomes in Patients With Non-ST Segment Elevation Myocardial Infarction
50. Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.